Secretary Blinken Addresses Global Synthetic Drug Threats at U.S.-Hosted Side Event on the Margins of UNGA78
Office of the Spokesperson On Monday, September 18, Secretary of State Antony J. Blinken hosted an event on the margins of the 78th United Nations General Assembly addressing the pressing issue of synthetic drug challenges worldwide. The U.S.-sponsored side event, titled “Addressing the Public Health and Security Threats of Synthetic Drugs Through Global Cooperation,” convened international leaders and representatives from international organizations, private sector, and civil society to discuss comprehensive strategies for combatting the public health and security threats posed by synthetic drugs and advance the work of the Global Coalition to Address Synthetic Drug Threats. As synthetic drugs continue to devastate communities at home and abroad, this discussion underscores the United States’ commitment to engaging with international partners to address this critical issue, including the provision of more than $100 million in assistance from the Department of State to build the capacity of partners across the world to detect, identify, and interdict synthetic drugs. This assistance also includes providing vital treatment, prevention, and recovery initiatives, as well as supporting alternatives to incarceration systems development with a focus on drug treatment. The Global Coalition provides a platform for the exchange of knowledge, ideas, and collaborative efforts aimed at dismantling the criminal networks responsible for the production and distribution of synthetic drugs and sharing universal best practices for substance use harm reduction and will continue expert-level engagement through monthly meetings launching in October. For further information, please e-mail INL-PAPD@state.gov or follow INL on Twitter at @StateINL .
Office of the Spokesperson
On Monday, September 18, Secretary of State Antony J. Blinken hosted an event on the margins of the 78th United Nations General Assembly addressing the pressing issue of synthetic drug challenges worldwide. The U.S.-sponsored side event, titled “Addressing the Public Health and Security Threats of Synthetic Drugs Through Global Cooperation,” convened international leaders and representatives from international organizations, private sector, and civil society to discuss comprehensive strategies for combatting the public health and security threats posed by synthetic drugs and advance the work of the Global Coalition to Address Synthetic Drug Threats.
As synthetic drugs continue to devastate communities at home and abroad, this discussion underscores the United States’ commitment to engaging with international partners to address this critical issue, including the provision of more than $100 million in assistance from the Department of State to build the capacity of partners across the world to detect, identify, and interdict synthetic drugs. This assistance also includes providing vital treatment, prevention, and recovery initiatives, as well as supporting alternatives to incarceration systems development with a focus on drug treatment. The Global Coalition provides a platform for the exchange of knowledge, ideas, and collaborative efforts aimed at dismantling the criminal networks responsible for the production and distribution of synthetic drugs and sharing universal best practices for substance use harm reduction and will continue expert-level engagement through monthly meetings launching in October.
For further information, please e-mail INL-PAPD@state.gov or follow INL on Twitter at @StateINL .
